| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $156.3M | +8.1% |
| Cost of Revenue | $96.3M | -38.1% |
| Gross Profit | $60.0M | +642.2% |
| R&D Expense | $35.3M | -31.2% |
| SG&A Expense | $51.6M | -41.4% |
| Operating Income | -$55.7M | +93.4% |
| Pre-tax Income | $138.3M | +116.2% |
| Income Tax | $536K | +61.4% |
| Net Income | $137.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.9M | -13.1% |
| Accounts Receivable | $38.4M | -35.3% |
| Inventory | $4.6M | -58.0% |
| Current Assets | $100.1M | -26.7% |
| Total Assets | $308.9M | -29.4% |
| Current Liabilities | $110.6M | -14.2% |
| Total Liabilities | $557.9M | -33.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.9M | +118.7% |
| Investing Cash Flow | -$6.6M | -87.7% |
| Financing Cash Flow | -$7.6M | +10.4% |
| +116.1% |
| EPS (Basic) | $16.52 | +412.3% |
| EPS (Diluted) | -$9.18 | -73.5% |
| Stockholders' Equity |
| -$249.4M |
| +37.4% |